30. Juni 2023 – The Complementary and Phytotherapeutic Products Ordinance (Komplementär- und Phytoarzneimittelverordnung, KPAV) provides for Asian medicinal products without indication a marketing authorisation based on a notification in accordance with art. 31 KPAV. The single notifications must be submitted in the form prescribed by Swissmedic according to art. 41 KPAV. Swissmedic provides a corresponding electronic form and has developed the HOMANT Asia software for this purpose. A new version of the HOMANT Asia software as an update can be downloaded free of charge from the Swissmedic website.

For more information, see here.